13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001442756
Total reported value
$1.2B
$1.2B
77 檔
52.1%
As reported in its official Q2 2024 Form 13F filing, PFM Health Sciences, LP's tracked investment portfolio stood at $1.2B with 77 total positions.
During Q2 2024, PFM Health Sciences, LP's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 13.38% | -1.48% | — | |
| 2 | CYTK | Cytokinetics Inc | Stock-Healthcare | 4.71% | +1.40% | NEW | |
| 3 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 4.44% | — | — | |
| 4 | THC | Tenet Healthcare CORP | Stock-Healthcare | 3.88% | -4.83% | — | |
| 5 | MRK | Merck & Co. Inc. | Stock-Healthcare | 3.65% | +1.40% | NEW | |
| 6 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 3.45% | — | — | |
| 7 | ABBV | Abbvie Inc | Stock-Healthcare | 3.43% | — | — | |
| 8 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 3.38% | +0.08% | — | |
| 9 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 3.07% | +1.72% | +529.30% | |
| 10 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 3.02% | — | +23.68% | |
| 11 | MCK | Mckesson CORP | Stock-Healthcare | 2.82% | — | — | |
| 12 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 2.73% | -5.30% | EXIT | |
| 13 | HUM | Humana Inc | Stock-Healthcare | 2.32% | +3.22% | NEW | |
| 14 | HCA | Hca Healthcare Inc | Stock-Healthcare | 1.98% | -0.49% | -36.51% | |
| 15 | CNC | Centene CORP | Stock-Healthcare | 1.96% | +1.07% | — | |
| 16 | UHS | Universal Health Services-b | Stock-Healthcare | 1.96% | — | — | |
| 17 | SYK | Stryker CORP | Stock-Healthcare | 1.92% | +0.87% | +107.47% | |
| 18 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 1.86% | +0.54% | — | |
| 19 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.85% | +0.06% | — | |
| 20 | ICLR | ICON Public Limited Company | Stock-Healthcare | 1.81% | +1.45% | +0.70% | |
| 21 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 1.74% | +0.57% | +9.67% | |
| 22 | PEN | Penumbra Inc | Stock-Healthcare | 1.65% | -2.56% | +18.82% | |
| 23 | DHR | Danaher CORP | Stock-Healthcare | 1.55% | — | — | |
| 24 | BDX | Becton Dickinson And Co | Stock-Healthcare | 1.52% | — | -23.42% | |
| 25 | ELV | Elevance Health Inc | Stock-Healthcare | 1.48% | — | — | |
| 26 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 1.40% | +0.09% | +56.93% | |
| 27 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.33% | — | +101.47% | |
| 28 | DXCM | Dexcom Inc | Stock-Healthcare | 1.30% | -0.86% | EXIT | |
| 29 | AMGN | Amgen Inc | Stock-Healthcare | 1.25% | — | — | |
| 30 | IQV | Iqvia Holdings Inc | Stock-Healthcare | 1.17% | — | — | |
| 31 | MOH | Molina Healthcare Inc | Stock-Healthcare | 1.03% | — | — | |
| 32 | ASND 2.25 04-01-28Bond | Ascendis Pharma A/s | Bond | 0.99% | -1.54% | EXIT | |
| 33 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.93% | — | — | |
| 34 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.93% | +0.07% | -5.12% | |
| 35 | ACLXGBX | Arcellx Inc | Stock-Other | 0.85% | — | +2.89% | |
| 36 | INSM | Insmed Inc | Stock-Healthcare | 0.80% | — | — | |
| 37 | EPIEUR | Essa Pharma Inc | Stock-Other | 0.77% | — | -0.50% | |
| 38 | BMRN 0.599 08-01-24Bond | Biomarin Pharmaceutical | Bond | 0.74% | — | — | |
| 39 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 0.71% | — | -62.34% | |
| 40 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 0.69% | — | +681.29% | |
| 41 | CELC | Celcuity Inc | Stock-Other | 0.68% | +0.47% | NEW | |
| 42 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 0.67% | +0.75% | — | |
| 43 | IMVT | Immunovant Inc | Stock-Other | 0.62% | — | — | |
| 44 | ITCIEUR | Intra-cellular Therapies Inc | Stock-Other | 0.58% | — | +72.33% | |
| 45 | ERAS | Erasca Inc | Stock-Other | 0.55% | +0.21% | NEW | |
| 46 | ADAPY | Adaptimmune Therapeutics-adr | Stock-Other | 0.51% | — | +0.93% | |
| 47 | SRPT 1.25 09-15-27Bond | Sarepta Therapeutics Inc | Bond | 0.49% | — | — | |
| 48 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.42% | -0.28% | — | |
| 49 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 0.39% | -0.30% | -41.19% | |
| 50 | HOWL | Werewolf Therapeutics Inc | Stock-Other | 0.39% | — | +7.79% |
According to official SEC Form 13F filings, PFM Health Sciences, LP reported a total U.S. public equity portfolio value of $1.2B across 77 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including LLY, CYTK, QQQ) accounted for 52.1% of total reported equity market value during Q2 2024.
During Q2 2024, PFM Health Sciences, LP's top holdings by market value included LLY (13.4%)、CYTK (4.7%)、QQQ (4.4%). The largest single position, LLY, represented 13.4% of total portfolio value.
In Q2 2024, PFM Health Sciences, LP made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.